EVALUATION OF PRESCRIPTIONS OF PHARMACEUTICALS USED TO WEIGHT REDUCTION PREPARED AT COMPOUNDING PHARMACY BEFORE AND AFTER RDC 52/2011

Authors

  • Hanan Jumah Eid Ahmah Laila Centro de Ciências da Saúde, Universidade da Região da Campanha
  • Ana Paula Simões Menezes Centro de Ciências da Saúde, Universidade da Região da Campanha
  • Marisa Fernanda da Silva Nunes Centro de Ciências da Saúde, Universidade da Região da Campanha
  • Roberta Nunes Horta Centro de Ciências da Saúde, Universidade da Região da Campanha
  • Ana Carolina Zago Centro de Ciências da Saúde, Universidade da Região da Campanha

DOI:

https://doi.org/10.14450/2318-9312.v25.e4.a2013.pp182-187

Keywords:

Obesity. Pharmacotherapy. Anorectics. Prescriptions

Abstract

The aim of this study was to evaluate prescriptions of pharmaceuticals used to weight loss in a compounding pharmacy
in the city of Pelotas – RS, before and after the term of the Anvisa RDC 52/2011. For this aim, prescriptions containing anorectic drugs were analyzed in the months from January to December in 2010 and 2012. The obtained results showed that women remain the gender that most consume these kind of drugs in both, 2010 and in 2012. In 2010, the most prescribed anorectic were respectively amfepramone (68.7%), femproporex (26.2%), mazindol (2.7%) and sibutramine (2.4%), and the general practitioners were most prevalent physicians prescribing these drugs at both evaluated periods. In 2012, there was a considerable increase in the prescription of sibutramine. However, the validity of the RDC 52/2011 was effective to promote the reduction in prescriptions of anorectic drugs and it is noticeable the importance of regulatory acts on the part of health authorities, regulating the rational use of medicines.

Downloads

Published

2013-12-30

How to Cite

Jumah Eid Ahmah Laila, H., Simões Menezes, A. P., Silva Nunes, M. F. da, Nunes Horta, R., & Zago, A. C. (2013). EVALUATION OF PRESCRIPTIONS OF PHARMACEUTICALS USED TO WEIGHT REDUCTION PREPARED AT COMPOUNDING PHARMACY BEFORE AND AFTER RDC 52/2011. Infarma - Pharmaceutical Sciences, 25(4), 182–187. https://doi.org/10.14450/2318-9312.v25.e4.a2013.pp182-187

Issue

Vol. 25 No. 4 (2013)

Section

Original article

License

Authors who publish in this journal agree to the following terms:

 

  1. Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
  2. Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
  3. Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).